对《对〈中国乙型肝炎病毒母婴传播防治指南(2019年版)〉的商榷》一文的回复

刘锦锋; 陈天艳; 陈耀龙; 赵英仁

doi:10.3969/j.issn.1001-5256.2020.01.014

对《对〈中国乙型肝炎病毒母婴传播防治指南(2019年版)〉的商榷》一文的回复

DOI: 10.3969/j.issn.1001-5256.2020.01.014

1. 西安交通大学第一附属医院感染科
2. 兰州大学基础医学院循证医学中心
3. 世界卫生组织指南实施与知识转化合作中心
4. GRADE中国中心

详细信息

中图分类号: R714.251
计量
- 文章访问数: 337
- HTML全文浏览量: 23
- PDF下载量: 144
- 被引次数: 0
出版历程
- 出版日期: 2020-01-20

Response to the article of “comments on 2019 Chinese practice for the prevention and treatment of hepatitis B virus mother-to-child transmission”

Department of Infectious Diseases,The First Affiliated Hospital of Xi'an Jiaotong University

摘要

摘要: <正>2011年,美国医学研究所(Institute of Medicine,IOM)对已使用20年的临床实践指南的定义进行了修改,强调指南应基于系统评价证据,平衡不同干预措施利弊,在此基础上形成能够为患者提供最佳保健服务的推荐意见[1]。《中国乙型肝炎病毒母婴传播防治指南(2019年版)》(下称《指南》)[2]由中华医学会感染病学分会发起,联合感染、肝病、妇产、生殖及循证医学等多学科专家,严格遵守IOM对指南的最新定义和《世界卫生组织指南制订手册》[3]的规范和流程,运用证据推荐分级的
- 乙型肝炎病毒 /
- 母婴传播阻断 /
- 诊疗准则(主题) /
- 循证医学
- hepatitis B virus /
- blocking mother-to-child transmission /
- practice guidelines as topic /
- evidence-based medicine

HTML全文

参考文献(18)

[1] Institute of Medicine(US). Clinical practice guidelines we can trust[M]. Washington,DC. The National Academies Press,2011.

[2] Chinese Society of Infectious Diseases,Chinese Medical Association; Chinese GRADE Center. Guidelines for the prevention and treatment of mother-to-child transmission of hepati-tis B virus in China(version 2019)[J]. Chin J Infect Dis,2019,37(7):388-396.(in Chinese)中华医学会感染病学分会，GRADE中国中心．中国乙型肝炎病毒母婴传播防治指南(2019年版)[J]．中华传染病杂志，2019,37(7):388-396.

[3] World Health Organization. WHO handbook for guideline development 2nd edition[M]. Geneva:WHO Press,2014.

[4] ATKINS D,BEST D,BRISS PA,et al. Grading quality of evidence and strength of recommendations[J]. BMJ,2004,328(7454):1490.

[5] OWENS DK,DAVIDSON KW,KRIST AH,et al. Medication use to reduce risk of breast cancer us preventive services task force recommendation statement[J]. JAMA,2019,322(9):857-867.

[6] NELSON HD,FU R,ZAKHER B,et al. Medication use for the risk reduction of primary breast cancer in women updated evidence report and systematic review for the US Preventive Services Task Force[J]. JAMA,2019,322(9):868-886.

[7] PRASAD K,SIEMIENIUK R,HAO Q,et al. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke:A clinical practice guideline[J]. BMJ,2018,363:k5130.

[8] HAO Q,TAMPI M,O'DONNELL M,et al. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack:Systematic review and meta-analysis[J]. BMJ,2018,363:k5108

[9] STERGIOU GS,PALATINI P,ASMAR R,et al. Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization(AAMI/ESH/ISO)[J]. J Hypertens,2019,37(3):459-466.

[10] BOUBOUCHAIROPOULOU N,KOLLIAS A,ATKINS N,et al.Validation of blood pressure monitors using the aami and iso protocols:An overview of their recent application[J]. J Hypertens,2016,34:e286-e286.

[11] BENDSTRUP E,WUYTS W,ALFARO T,et al. Nintedanib in idiopathic pulmonary fibrosis:Practical management recommendations for potential adverse events[J]. Respiration,2019,97(2):173-184.

[12] NOTH I,WIJSENBEEK M,KOLB M,et al. Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials[J]. Am J Respir Crit Care Med,2017,195:a5383.

[13] Chinese Prevention Medicine Association; National Immunization Program,Chinese Center for Disease Control and Prevention. Technical guide for adult hepatitis B immunization in China[J]. Chin J Viral Dis,2012,2(1):11-16.(in Chinese)中华预防医学会，中国疾病预防控制中心免疫规划中心．中国成人乙型肝炎免疫预防技术指南[J]．中国病毒病杂志，2012,2(1):11-16.

[14] Chinese Menopause Society. 2018 Chinese guideline on menopause management and menopause hormone therapy[J]. Chin J Obstetr Gynecol,2018,53(11):729-739.(in Chinese)中华医学会妇产科学分会绝经学组．绝经管理与绝经激素治疗中国指南(2018)[J]．中华妇产科杂志，2018,53(11):729-739.

[15] JOURDAIN G,NGO-GIANG-HUONG N. HARRISON L,et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B[J]. N Engl J Med,2018,378(10):911-923.

[16] PAN CQ,DUAN Z,DAI E,et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load[J]. N Engl J Med,2016,374(24):2324-233.

[17] TIAN YT. The current status of 95%diagnostic criteria developed by foreign countries needs to be changed in China[N].Guangming Daily,2016-12-20(8).(in Chinese)田雅婷．我国95%诊断标准外国制定现状需改变[N]．光明日报，2016-12-20(8).

[18] CHEN YL,WANG C．“A Chinese path”for clinical practice guidelines[N]. Health News,2018-02-26(5).(in Chinese)陈耀龙，王辰．临床实践指南寻觅“中国道路”[N]．健康报，2018-02-26(5).

施引文献

资源附件(0)

访问统计